Easy To Use Patents Search & Patent Lawyer Directory
At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.
Searching:
Search by keyword, patent number, inventor, assignee, city or state:
| Patent # | Description |
|---|---|
| US-1,001,0529 |
Extended release pharmaceutical formulations with controlled impurity
levels The present invention provides extended release pharmaceutical formulations of valsartan with controlled impurity levels. Particularly, the present invention... |
| US-1,001,0527 |
Active metabolite of
1-[(2-bromophenyl)sulfonyl]-5-methoxy-3-[(4-methyl-1-piperazinyl)methyl]--
1H-indole... The present invention is directed to active metabolite of 1-[(2-bromophenyl)sulfonyl]-5-methoxy-3-[(4-methyl-1-piperazinyl)methyl]-- 1H-indole dimesylate... |
| US-1,001,0526 |
Heterocyclic flavone derivatives, compositions, and methods related
thereto In certain embodiments, the disclosure relates to heterocyclic flavone derivatives, such as those described by formula provided herein, pharmaceutical... |
| US-1,001,0525 |
Methods of inducing anesthesia The present invention provides methods for determining the selectivity of an anesthetic for an anesthetic-sensitive receptor by determining the molar water... |
| US-1,001,0524 |
Short acting phenylalkylamine calcium channel blockers and uses thereof The present invention relates to the use of a pharmaceutically effective amount of an short-acting calcium channel blocking compound to treat ischemic heart... |
| US-1,001,0523 |
Short acting phenylalkylamine calcium channel blockers and uses thereof The present invention relates to the use of a pharmaceutically effective amount of an short-acting calcium channel blocking compound to treat ischemic heart... |
| US-1,001,0522 |
Short acting phenylalkylamine calcium channel blockers and uses thereof The present invention relates to the use of a pharmaceutically effective amount of an short-acting calcium channel blocking compound to treat ischemic heart... |
| US-1,001,0521 |
SARMs and method of use thereof This invention is directed to substituted acylanilide compounds and uses thereof in improving or preserving lung function and cardiac function in a subject... |
| US-1,001,0520 |
Combined application of isothiocyanate compound and anti-cancer medicine The present invention relates to a combined application of isothiocyanate compounds and anti-cancer drugs, in particular to a composition, comprising: (A) a... |
| US-1,001,0519 |
Compositions and methods of use of phorbol esters for the treatment of
stroke Methods and compositions containing a phorbol ester or a derivative of a phorbol ester are provided for the treatment and prevention of stroke and the sequelae... |
| US-1,001,0518 |
Prostacyclin compounds, compositions and methods of use thereof Prostacyclin compounds and compositions comprising the same are provided herein. Specifically, prostacyclin compounds comprising treprostinil covalently linked... |
| US-1,001,0517 |
Stable pharmaceutical composition and methods of using same The present invention relates to, inter alia, pharmaceutical compositions comprising a polyunsaturated fatty acid and to methods of using the same to treat or... |
| US-1,001,0516 |
Method for regulating retinal endothelial cell viability Here provided is a method for regulating retinal endothelial cell viability in a mammal by administering to the mammal a therapeutically effective amount of a... |
| US-1,001,0515 |
Therapeutic approaches for treating Parkinson's disease The present invention relates to compositions and methods for the treatment of Parkinson's disease and related disorders. More specifically, the present... |
| US-1,001,0514 |
Pharmaceutical formulation for reducing frequency of urination and method
of use thereof Methods and compositions for reducing frequency of urination are disclosed. The methods comprise administering to a subject having a condition that resulting in... |
| US-1,001,0513 |
Aqueous pharmaceutical composition containing a biologic therapeutic agent
and guanidine or a guanidine... The present invention is directed to an aqueous pharmaceutical composition, particularly an aqueous ophthalmic composition, suitable as an injection,... |
| US-1,001,0512 |
Methods of treating diseases associated with high-fat diet and vitamin A
deficiency using retinoic acid... This invention relates to pharmaceutical composition and methods of using vitamin A and/or RAR.beta. agonist for the treatment or prevention of diseases or... |
| US-1,001,0511 |
Transdermal drug delivery system A transdermal drug delivery system is provided that includes a drug-in-adhesive matrix layer and a backing layer. The matrix layer includes an active... |
| US-1,001,0510 |
Oral pharmaceutical formulation Described herein are oral pharmaceutical formulations comprising a core component and a coating composition applied on the core component. Also described is a... |
| US-1,001,0509 |
Apparatus and method for producing controlled dosage of bioactive agent An apparatus for producing a controlled dosage of bioactive agent is disclosed. The apparatus includes: a print device to eject a drop of a mixture onto an... |
| US-1,001,0508 |
MTAB-TA-Coated gold nanorods and method of fabrication 11-mercaptoundecyl trimethylammonium bromide gold nanorod (MTAB-GNR) coated with tannic acid (TA), useful for biological cellular imaging. A method of... |
| US-1,001,0507 |
Pharmaceutical formulations of a bruton's tyrosine kinase inhibitor Described herein are pharmaceutical formulations of Bruton's tyrosine kinase (Btk) inhibitor ... |
| US-1,001,0506 |
Matrix and layer compositions for protection of bioactives The invention relates to matrix and layer compositions comprising a first polymer. The matrix and layer compositions are useful in the delivery of bioactives.... |
| US-1,001,0505 |
Liposomes active in-vivo on neurodegenerative diseases New liposomes are described, comprising: (i) phosphatidic acid and/or cardiolipin; (ii) apolipoprotein E (ApoE) or derivatives thereof. The so modified... |
| US-1,001,0504 |
Compositions and methods including celecoxib and plumbagin relating to
treatment of cancer The present invention relates to compositions and methods for treatment of proliferative disease. In specific aspects, the present invention relates to... |
| US-1,001,0503 |
Methods and compositions for oral administration This invention provides compositions comprising a protein, an absorption enhancer, a protease inhibitor, method for treating diabetes mellitus, comprising... |
| US-1,001,0502 |
Device that delivers a sustained low-dose of a myopia-suppressing drug,
while preserving pupillary function and... A non-degradable topical ocular drug delivery device includes about 0.001% to about 10% w/w of at least one myopia-suppressing agent complexed with an immobile... |
| US-1,001,0501 |
Process for making controlled release medical implant products A method (and the resulting product) of making a medical implant device for releasing self-contained drugs on a controlled basis wherein the method utilizes, at... |
| US-1,001,0500 |
Ceramic implants affording controlled release of active materials Implantable compositions providing release of bioactive agents according to a predetermined release profile and methods for their use. Such compositions include... |
| US-1,001,0499 |
Methods of using microneedle vaccine formulations to elicit in animals
protective immunity against rabies virus The present invention relates to microneedle vaccine formulations, as well as methods of use thereof to provide animals, including canines, protective immunity... |
| US-1,001,0498 |
Methods for treatment of amyotrophic lateral sclerosis with follistatin
fusion proteins The disclosure provides, in part, follistatin polypeptides that are suitable for use in local administration and methods for use. |
| US-1,001,0497 |
Cosmetic preparation containing crosslinkable silicone rubber emulsion and
its production method A cosmetic preparation containing a crosslinkable silicone rubber emulsion comprising (A) 100 parts by weight of a straight chain or branched organopolysiloxane... |
| US-1,001,0496 |
Topical sanitizing formulations and uses thereof Several embodiments disclosed herein relate to formulations having antimicrobial and/or sanitizing effects, and uses of the same. In particular, the... |
| US-1,001,0495 |
Hair dyeing process using at least one ortho-diphenol and one organic salt
of titanium and of a carboxylic acid The present invention relates to a process for dyeing keratin fibers, in particular human keratin fibers such as the hair, in which the said fibers are treated... |
| US-1,001,0494 |
Methods for the treatment of hyperhidrosis The present invention relates in general to methods of treating sweating disorders and in particular to topical compositions for the treatment of hyperhidrosis.... |
| US-1,001,0493 |
Ester compound, and cosmetic component and cosmetic product each
containing same The purpose of the present invention is to provide a novel ester compound which can be used as a component of a cosmetic component. An ester compound of... |
| US-1,001,0492 |
Methods and compositions for treating skin to resolve inflammation and
screening for actives that stimulate... Compositions and methods for treating inflamed skin with Pro-Resolution Pathway Stimulators that may be Inflammatory Metabolite Inhibitors, Pro-Resolving... |
| US-1,001,0491 |
Oral care composition An oral care composition is disclosed comprising calcium silicate and high refractive index particles wherein the calcium silicate and high refractive index... |
| US-1,001,0490 |
Cosmetic composition comprising cellulose fibers with small fiber diameter
and comparatively small aspect ratio There is provided a cosmetic additive in which the cosmetic obtained by mixing has excellent transparency, and good spread and feeling of use during... |
| US-1,001,0489 |
Cosmetic preparation comprising pulverized hydrophilic substances A substance, which is in principle insoluble in a cosmetic or dermatological anhydrous preparation is converted into a powdery product by absorption onto a... |
| US-1,001,0488 |
Dental composition and use thereof A dental composition comprising a polymerizable monomer (1), initiator, filler component(s) in an amount of more than about 20 wt.-%, wt.-% with respect to the... |
| US-1,001,0487 |
Containers with penetrable and resealable portion, and related methods An apparatus is provided for receiving a substance, and includes a body defining a chamber for receiving the substance; and a dome-shaped needle penetrable and... |
| US-1,001,0486 |
Adjustable indicators for container assemblies Adjustable indicators for containers and methods for using and making the same are provided. In one example embodiment, a cap for a bottle includes a closure... |
| US-1,001,0485 |
Medicine feeding unit A medicine feeding unit configured to feed solid medicines, the unit including: a medicine feeder having a driven shaft and a support having a driving shaft... |
| US-1,001,0484 |
Multi-size pill splitter and methods A pill splitter for cutting pills and tablets of multiple sizes into uniform dosage portions for treating humans or animals comprising a housing, a rotatable... |
| US-1,001,0483 |
Cassette assembly for syringe fill system A syringe fill system is described, which is useful for filling syringes for dental anesthetic applications. The system incorporates capability for "push-pull",... |
| US-1,001,0482 |
Syringe fill system and method A syringe fill system is described, which is useful for filling syringes for dental anesthetic applications. The system incorporates capability for "push-pull",... |
| US-1,001,0481 |
Flexible package with a sealed sterile chamber for the reconsitution and
administration of fluid medicinal or... A package for infusion or instillation of medicinal or nutritional products into the body of a patient comprises a bag of liquid diluent equipped with at least... |
| US-1,001,0480 |
Absorbing layer for blister package, laminate comprising same, and blister
package using said laminate The purpose of the present invention is to provide an absorbent layer for blister packs, which imparts sufficient formability and is free from forming failure... |
| US-1,001,0479 |
System and method for auricular peripheral nerve field stimulation An auricular peripheral nerve field stimulator system includes an electrical stimulation device for generating electrical stimulation signals and a plurality of... |
File A Patent Application
- Protect your idea -- Don't let someone else file first. Learn more.
- 3 Easy Steps -- Complete Form, application Review, and File. See our process.
- Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.